126 related articles for article (PubMed ID: 37337830)
1. 6-Shogaol, an Active Ingredient of Ginger, Improves Intestinal and Brain Abnormalities in
Huh E; Choi JG; Choi Y; Ju IG; Noh D; Shin DY; Kim DH; Park HJ; Oh MS
Biomol Ther (Seoul); 2023 Jul; 31(4):417-424. PubMed ID: 37337830
[TBL] [Abstract][Full Text] [Related]
2. Ginger and 6-shogaol protect intestinal tight junction and enteric dopaminergic neurons against 1-methyl-4-phenyl 1,2,3,6-tetrahydropyridine in mice.
Huh E; Choi JG; Noh D; Yoo HS; Ryu J; Kim NJ; Kim H; Oh MS
Nutr Neurosci; 2020 Jun; 23(6):455-464. PubMed ID: 30230979
[No Abstract] [Full Text] [Related]
3. Oral administration of Proteus mirabilis damages dopaminergic neurons and motor functions in mice.
Choi JG; Kim N; Ju IG; Eo H; Lim SM; Jang SE; Kim DH; Oh MS
Sci Rep; 2018 Jan; 8(1):1275. PubMed ID: 29352191
[TBL] [Abstract][Full Text] [Related]
4. P. mirabilis-derived pore-forming haemolysin, HpmA drives intestinal alpha-synuclein aggregation in a mouse model of neurodegeneration.
Huh E; Choi JG; Choi Y; Ju IG; Kim B; Shin YJ; An JM; Park MG; Yim SV; Chung SJ; Seo SU; Kim D; Kim CH; Kim DH; Oh MS
EBioMedicine; 2023 Dec; 98():104887. PubMed ID: 37995468
[TBL] [Abstract][Full Text] [Related]
5. 6-Shogaol, an active constituent of ginger, attenuates neuroinflammation and cognitive deficits in animal models of dementia.
Moon M; Kim HG; Choi JG; Oh H; Lee PK; Ha SK; Kim SY; Park Y; Huh Y; Oh MS
Biochem Biophys Res Commun; 2014 Jun; 449(1):8-13. PubMed ID: 24796668
[TBL] [Abstract][Full Text] [Related]
6. Could the Urease of the Gut Bacterium
Grahl MVC; Andrade BDS; Perin APA; Neves GA; Duarte LS; Uberti AF; Hohl KS; Follmer C; Carlini CR
Microorganisms; 2023 Aug; 11(8):. PubMed ID: 37630602
[TBL] [Abstract][Full Text] [Related]
7. Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis.
Zhao Z; Ning J; Bao XQ; Shang M; Ma J; Li G; Zhang D
Microbiome; 2021 Nov; 9(1):226. PubMed ID: 34784980
[TBL] [Abstract][Full Text] [Related]
8. The role of the microbiota-gut-brain axis and intestinal microbiome dysregulation in Parkinson's disease.
Li Q; Meng LB; Chen LJ; Shi X; Tu L; Zhou Q; Yu JL; Liao X; Zeng Y; Yuan QY
Front Neurol; 2023; 14():1185375. PubMed ID: 37305758
[TBL] [Abstract][Full Text] [Related]
9. Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease.
Dodiya HB; Forsyth CB; Voigt RM; Engen PA; Patel J; Shaikh M; Green SJ; Naqib A; Roy A; Kordower JH; Pahan K; Shannon KM; Keshavarzian A
Neurobiol Dis; 2020 Feb; 135():104352. PubMed ID: 30579705
[TBL] [Abstract][Full Text] [Related]
10. Intestinal Barrier Dysfunction in the Absence of Systemic Inflammation Fails to Exacerbate Motor Dysfunction and Brain Pathology in a Mouse Model of Parkinson's Disease.
Jackson A; Engen PA; Forsyth CB; Shaikh M; Naqib A; Wilber S; Frausto DM; Raeisi S; Green SJ; Bradaric BD; Persons AL; Voigt RM; Keshavarzian A
Front Neurol; 2022; 13():882628. PubMed ID: 35665034
[TBL] [Abstract][Full Text] [Related]
11. Peripheral metabolic alterations associated with pathological manifestations of Parkinson's disease in gut-brain axis-based mouse model.
Huh E; Choi JG; Lee MY; Kim JH; Choi Y; Ju IG; Eo H; Park MG; Kim DH; Park HJ; Lee CH; Oh MS
Front Mol Neurosci; 2023; 16():1201073. PubMed ID: 37635904
[TBL] [Abstract][Full Text] [Related]
12. Polymannuronic acid prevents dopaminergic neuronal loss via brain-gut-microbiota axis in Parkinson's disease model.
Dong XL; Wang X; Liu F; Liu X; Du ZR; Li RW; Xue CH; Wong KH; Wong WT; Zhao Q; Tang QJ
Int J Biol Macromol; 2020 Dec; 164():994-1005. PubMed ID: 32710966
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective Effects of 6-Shogaol and Its Metabolite, 6-Paradol, in a Mouse Model of Multiple Sclerosis.
Sapkota A; Park SJ; Choi JW
Biomol Ther (Seoul); 2019 Mar; 27(2):152-159. PubMed ID: 30001610
[TBL] [Abstract][Full Text] [Related]
14. Curcumin-driven reprogramming of the gut microbiota and metabolome ameliorates motor deficits and neuroinflammation in a mouse model of Parkinson's disease.
Cui C; Han Y; Li H; Yu H; Zhang B; Li G
Front Cell Infect Microbiol; 2022; 12():887407. PubMed ID: 36034698
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective Effects of Shogaol in Metals (Al, As and Pb) and High-fat diet-induced Neuroinflammation and Behavior in Mice.
Ishaq S; Siyar S; Basri R; Liaqat A; Hameed A; Ahmed T
Curr Mol Pharmacol; 2023; 16(7):725-750. PubMed ID: 36173059
[TBL] [Abstract][Full Text] [Related]
16. Cholecystokinin and glucagon-like peptide-1 analogues regulate intestinal tight junction, inflammation, dopaminergic neurons and α-synuclein accumulation in the colon of two Parkinson's disease mouse models.
Su Y; Liu N; Zhang Z; Li H; Ma J; Yuan Y; Shi M; Liu J; Zhao Z; Zhang Z; Holscher C
Eur J Pharmacol; 2022 Jul; 926():175029. PubMed ID: 35584709
[TBL] [Abstract][Full Text] [Related]
17. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.
Caputi V; Giron MC
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882798
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective Effects of Sodium Butyrate by Restoring Gut Microbiota and Inhibiting TLR4 Signaling in Mice with MPTP-Induced Parkinson's Disease.
Guo TT; Zhang Z; Sun Y; Zhu RY; Wang FX; Ma LJ; Jiang L; Liu HD
Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839287
[TBL] [Abstract][Full Text] [Related]
19. Suppression of neuroinflammation and α-synuclein oligomerization by rotarod walking exercise in subacute MPTP model of Parkinson's disease.
Leem YH; Park JS; Park JE; Kim DY; Kim HS
Neurochem Int; 2023 May; 165():105519. PubMed ID: 36931345
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory effect and signaling mechanism of 8-shogaol and 10-shogaol in a dextran sodium sulfate-induced colitis mouse model.
Kim HR; Noh EM; Kim SY
Heliyon; 2023 Jan; 9(1):e12778. PubMed ID: 36647352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
